FDA Drug Safety Communications: A Narrative Review and Clinical Considerations for Older Adults
Author:
Publisher
Elsevier BV
Subject
Pharmacology (medical),Geriatrics and Gerontology
Reference33 articles.
1. Impact of FDA drug risk communications on health care utilization and health behaviors: a systematic review;Dusetzina;Med Care,2012
2. Improve the Food and Drug Administration's mandate to ensure postmarketing drug safety;Qato;JAMA,2011
3. The US Food and Drug Administration's sentinel initiative: expanding the horizons of medical product safety;Robb;Pharmacoepidem Drug Saf,2012
4. Ethical and Scientific Issues in Studying the Safety of Approved Drugs,2012
5. Celexa [package insert],2011
Cited by 68 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Postoperative ileus in obstetric and gynecological practice: a prospective solution to the problem;Medical alphabet;2024-09-06
2. Enhancing readability of USFDA patient communications through large language models: a proof-of-concept study;Expert Review of Clinical Pharmacology;2024-06-04
3. Side effects of proton pump inhibitors with long-term use: focus on the urinary system;Medical alphabet;2024-05-07
4. Investigating bleeding adverse events associated with BTK inhibitors in the food and drug administration adverse event reporting system (FAERS);Expert Opinion on Drug Safety;2024-04-08
5. Les statines : entre preuves scientifiques et perceptions des patients et des soignants;Archives des Maladies du Coeur et des Vaisseaux - Pratique;2024-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3